Home » Topics » BioWorld Science

BioWorld Science
RSS

BCL2 coding mutation is associated with venetoclax resistance in CLL

Dec. 20, 2018

Araxes Pharma presents mutant RAS inhibitors

Dec. 20, 2018

Silence Therapeutics adds LP(a)-targeting siRNA medicine SLN-360 to preclinical pipeline

Dec. 20, 2018

PsychENCODE casts light on genetics of psychiatric diseases

Dec. 20, 2018

Sabutoclax as potential new strategy for patients with chemoresistant breast cancer

Dec. 20, 2018

Dexmedetomidine can be used to treat agitation without affecting blood pressure or heart rate

Dec. 20, 2018

Bacterial toxins weaken gut barrier

Dec. 20, 2018

Less is more for durable STING effects

Dec. 20, 2018

Lilly begins phase III study of tirzepatide in patients with type 2 diabetes and cardiovascular risk

Dec. 20, 2018

HAL Allergy begins first-in-human study of HAL-MRE1 in ragweed allergic patients

Dec. 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...